Epidemiology of breast cancer - Current figures and trends

Geburtshilfe und Frauenheilkunde

Volumn 73, Issue 2, 2013, Pages 130-135

  Eisemann, N ^a   Waldmann, A ^b   Katalinic, A ^a  

^a Institut für Krebsepidemiologie   (Germany)

^b Institut Für Sozialmedizin Und Epidemiologie   (Germany)

Author keywords

breast cancer; epidemiology; incidence; mortality; prevalence; prognosis

Indexed keywords

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; GERMANY; HISTOLOGY; HUMAN; MAMMOGRAPHY; PREVALENCE; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION;

EID: 84874642212     PISSN: 00165751     EISSN: 14388804     Source Type: Journal    
DOI: 10.1055/s-0032-1328075     Document Type: Article

References (20)

1. (GEKID) Association of Population-based Cancer Registries in Germany and Robert Koch Institute eds. Cancer in Germany 2007/2008. Incidence and Trends. 8th revised edition. Berlin: 2012
2. Atlas der Krebsinzidenz und -mortalität. Internet: http://www.gekid.de last access: 8.10.2012
3. Kooperationsgemeinschaft Mammographie eds. Evaluationsbericht 2008 - 2009. Ergebnisse des Mammographie-Screening-Programms in Deutschland. Berlin: 2012
4. Gennaro G., Hendrick R. E., Ruppel P. et al. Performance comparison of single-view digital breast tomosynthesis plus single-view digital mammography with two-view digital mammography. Eur Radiol: 2012; Sep 14 [Epub ahead of print]
5. Michell M. J., Iqbal A., Wasan R. K. et al. A comparison of the accuracy of film-screen mammography, full-field digital mammography, and digital breast tomosynthesis. Clin Radiol: 2012; 67 976 981
6. Noroozian M., Hadjiiski L., Rahnama-Moghadam S. et al. Digital breast tomosynthesis is comparable to mammographic spot views for mass characterization. Radiology: 2012; 262 61 68
7. Svahn T. M., Chakraborty D. P., Ikeda D. et al. Breast tomosynthesis and digital mammography: a comparison of diagnostic accuracy. Br J Radiol: 2012; 85 e1074 e1082
8. Albert U-S. Stufe-3-Leitlinie - Brustkrebs-Früherkennung in Deutschland. 1. Aktualisierung. München, Wien, New York W. Zuckschwerdt Verlag: 2008
9. Gesundheitsberichterstattung des Bundes. Internet: http://www.gbe-bund.de last access: 8.10.2012
10. Katalinic A., Pritzkuleit R., Waldmann A. Recent trends in breast cancer incidence and mortality in Germany. Breast Care: 2009; 4 75 80
11. Esserman L., Shieh Y., Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA: 2009; 302 1685 1692
12. Independent UK Panel on Breast Cancer Screening The benefits and harms of breast cancer screening: an independent review. Lancet: 2012; 380 1778 1786
13. Karim-Kos H. E., de Vries E., Soerjomataram I. et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer: 2008; 44 1345 1389
14. Globocan 2008 Database. Internet: http://www-dep.iarc.fr/globocan/ database.htm last access: 8. 10. 2012
15. ECO website: European Cancer Observatory: Cancer incidence, mortality, prevalence and survival in Europe. Version 1.0 (September 2012). European Network of Cancer Registries, International Agency for Research on Cancer. Internet: http://eco.iarc.fr last access: 8.10.2012
16. Machleidt A., Diermeier-Daucher S., Mögele M. et al. Her4-JMa-Rezeptor als positiv prognostischer Marker in triple negativen Mammakarzinomen. Geburtsh Frauenheilk: 2012; 72 - P57
17. Untch M. Die neue Leitlinie der Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) zur operativen Therapie der Axilla bei Mammakarzinom. Geburtsh Frauenheilk: 2011; 71 - B25
18. Schmidt M., Fasching P. A., Beckmann M. W. et al. Biomarkers in breast cancer - an update. Geburtsh Frauenheilk: 2012; 72 819 832
19. Lüftner D., Lux M. P., Maass N. et al. Advances in breast cancer - looking back over the year. Geburtsh Frauenheilk: 2012; 72 1117 1129
20. Kolberg H-C, Lüftner D., Lux M. P. et al. Breast cancer 2012 - new aspects. Geburtsh Frauenheilk: 2012; 72 602 615